An AI diagnostics startup has raised $45 million in Series B funding to expand its telemedicine platform and speed up deployment of its remote monitoring tools. The company says the capital will support broader use of its FDA-cleared system, which analyzes wearable sensor data to help identify early signs of cardiac and metabolic conditions.

The funding round is aimed at increasing access to clinical screening in remote-care settings, where patients may not have frequent in-person visits. By processing data from connected devices, the platform is designed to help clinicians flag potential health risks sooner and guide follow-up care.

The company has positioned its technology at the intersection of digital health, diagnostics, and telemedicine, a sector that continues to draw investor interest as health systems look for more scalable ways to monitor patients outside hospitals and clinics. The new capital is expected to help with product expansion and commercial rollout.

No further financial terms or investor details were disclosed in the summary provided. The company did not say how quickly the broader deployment will take place.